High EGFR gene copy number predicts poor outcome in triple-negative breast cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

High EGFR gene copy number predicts poor outcome in triple-negative breast cancer

Published:2014-01-10 Issue:9 Volume:27 Page:1212-1222
ISSN:0893-3952
Container-title:Modern Pathology
language:en
Short-container-title:Mod Pathol

Author:

Park Heae Surng,Jang Min Hye,Kim Eun Joo,Kim Hyun Jeong,Lee Hee Jin,Kim Yu Jung,Kim Jee Hyun,Kang Eunyoung,Kim Sung-Won,Kim In Ah,Park So Yeon

Publisher

Springer Science and Business Media LLC

Subject

Pathology and Forensic Medicine

Link

http://www.nature.com/articles/modpathol2013251.pdf

Reference35 articles.

1. Bauer KR, Brown M, Cress RD et al. Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California cancer Registry. Cancer 2007;109:1721–1728.

2. Dent R, Trudeau M, Pritchard KI et al. Triple-negative breast cancer: clinical features and patterns of recurrence. Clin Cancer Res 2007;13:4429–4434.

3. Reis-Filho JS, Tutt AN . Triple negative tumours: a critical review. Histopathology 2008;52:108–118.

4. Haffty BG, Yang Q, Reiss M et al. Locoregional relapse and distant metastasis in conservatively managed triple negative early-stage breast cancer. J Clin Oncol 2006;24:5652–5657.

5. Liedtke C, Mazouni C, Hess KR et al. Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer. J Clin Oncol 2008;26:1275–1281.

Cited by 219 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CDK9 inhibitors for the treatment of solid tumors;Biochemical Pharmacology;2024-11

2. AGR2 facilitates teratoma progression by regulating glycolysis via the AnXA2/EGFR axis;Experimental Cell Research;2024-09

3. Generation of Novel Tumour-Selective SEA Superantigen-Based Peptides with Improved Safety and Efficacy for Precision Cancer Immunotherapy;International Journal of Molecular Sciences;2024-08-30

4. Navigating cancer therapy induced cardiotoxicity: From pathophysiology to treatment innovations;Advanced Drug Delivery Reviews;2024-08

5. Prioritizing drug targets by perturbing biological network response functions;PLOS Computational Biology;2024-06-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3